Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
Nooms GLP-1 Companion drives 10x the engagement of the average health app and members in the top quartile of app engagement stay on GLP-1 medication more than twice as long, with 2.4x higher odds of maintaining their habits after stopping
Learn more about us and how we prioritize patient safety and accuracy in our doctor-led weight loss program
The much larger, headline-grabbing numbers associated with cagrilintide in the press figures in the low-to-mid 20% range come from Phase 3 trials of CagriSema , the combination with semaglutide, and are company-reported topline results, not standalone-cagrilintide data and not the peer-reviewed Phase 2 result cited above
Metabolic improvements from tirzepatide can also affect pain perception
& Krammer, F
